DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02617 TRANSTHERA-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Frank Wu (32.97%)
Chan Tan Ching Fen (6.96%)
Future Industry Investment Fund II (Limited Partnership) (6.12%)
PharmaBlock Sciences (Nanjing), Inc. (5.57%)
SDIC Venture Capital Co., Ltd (5.46%)
CPE Management International II Limited (5.42%)		 Sector Health Care & Biotechnology
Web Site http://www.transthera.com Tel (86-25) 5821-6200
Email ir@transtherabio.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the research and development of pharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top